# Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

> **NCT01155934** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Risperidone Orally Disintegrating Tablets

## Key facts

- **NCT ID:** NCT01155934
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2004-08
- **Final completion:** 2004-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2010-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155934, "Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01155934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*